Earnings History Data for Amylyx Pharmaceuticals, Inc. (AMLX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		AMLX	Amylyx Pharmaceuticals, Inc.	395.56	-0.53	-0.47	0.30		6.49	0.27 (4.26%)	6.01	-0.21 (-3.38%)	1.58 - 19.95	1,549,222	1,350,000	38,874

08-08-2024	PM		AMLX	Amylyx Pharmaceuticals, Inc.	133.97	-0.73	-0.38	0.31	Amylyx Pharmaceuticals GAAP EPS of -$1.07 [8/8/2024 8:48 AM]	1.80	-0.08 (-4.26%)	1.88	0.0 (0.00%)	1.58 - 22.36	887,421	1,100,000	5,101
Amylyx Pharmaceuticals GAAP EPS of -$1.07 [8/8/2024 8:48 AM]
09-05-2024	PM		AMLX	Amylyx Pharmaceuticals, Inc.	133.53	-0.46	0.24	0.02	Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M [5/9/2024 7:16 AM]	1.88	-0.05 (-2.59%)	1.84	-0.09 (-4.66%)	1.70 - 30.50	2,858,113	2,080,000	131,637
Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M [5/9/2024 7:16 AM] Amylyx Pharmaceuticals Q1 2024 Earnings Preview [5/8/2024 11:43 AM]
22-02-2024	PM		AMLX	Amylyx Pharmaceuticals, Inc.	1,070	0.07	0.20	-0.65	Amylyx Pharmaceuticals GAAP EPS of $0.07 misses by $0.16, revenue of $108.4M beats by $1.36M [2/22/2024 7:03 AM]	18.46	3.15 (20.61%)	16.62	1.31 (8.56%)	11.82 - 38.32	5,100,760	970,000	204,617
Amylyx Pharmaceuticals Q4 2023 Earnings Preview [2/21/2024 11:02 AM] Amylyx Pharmaceuticals GAAP EPS of $0.07 misses by $0.16, revenue of $108.4M beats by $1.36M [2/22/2024 7:03 AM] Amylyx climbs after Q4 revenue beat and pipeline update [2/22/2024 11:28 AM]
09-11-2023	PM		AMLX	Amylyx Pharmaceuticals, Inc.	1,230	0.30	0.42	-0.92	Amylyx Pharmaceuticals GAAP EPS of $0.30 misses by $0.12, revenue of $102.7M misses by $10.96M [11/9/2023 7:38 AM]	12.31	-5.69 (-31.58%)	12.62	-5.38 (-29.89%)	12.24 - 41.93	9,348,814	1,340,000	543,070
Amylyx Pharmaceuticals GAAP EPS of $0.30 misses by $0.12, revenue of $102.7M misses by $10.96M [11/9/2023 7:38 AM]
10-08-2023	AH		AMLX	Amylyx Pharmaceuticals, Inc.	1,460	0.31	0.01	-0.93	Amylyx Pharmaceuticals GAAP EPS of $0.31 beats by $0.35, revenue of $98.2M beats by $6.06M [8/10/2023 4:30 PM]	21.63	0.46 (2.17%)	21.20	0.03 (0.14%)	15.80 - 41.93	1,700,051	1,110,000	5,154
Amylyx Pharmaceuticals GAAP EPS of $0.31 beats by $0.35, revenue of $98.2M beats by $6.06M [8/10/2023 4:30 PM]
11-05-2023	AH	4:00 PM ET (May 11)	AMLX	Amylyx Pharmaceuticals, Inc.	2,010	0.02	-0.27	-0.93	Amylyx Pharmaceuticals GAAP EPS of $0.02 beats by $0.24, revenue of $0.07M misses by $59.58M [5/11/2023 4:06 PM]	27.67	-1.15 (-3.99%)	30.50	1.68 (5.83%)	6.51 - 41.93	2,850,096	750,000	73,658
Amylyx Pharmaceuticals GAAP EPS of $0.02 beats by $0.24, revenue of $71.43M beats by $11.78M [5/11/2023 4:06 PM]
13-03-2023	AH	4:00 PM ET (Mar 13)	AMLX	Amylyx Pharmaceuticals, Inc.	2,400	-0.65	-0.77	0.00	Amylyx Pharmaceuticals GAAP EPS of -$0.65 beats by $0.16, revenue of $21.89M beats by $17.17M [3/13/2023 4:27 PM]	34.21	3.04 (9.75%)	37.23	6.06 (19.44%)	6.51 - 41.93	3,768,472	780,000	84,457
Amylyx Pharmaceuticals GAAP EPS of -$0.65 beats by $0.16, revenue of $21.89M beats by $17.17M [3/13/2023 4:27 PM] Amylx Pharmaceuticals jumps 20% on Q4 top and bottom line beats [3/13/2023 6:18 PM] Hot Stocks: FRC, WAL, KEY rebound; BG higher on replacing SBNY in S&P 500; NTCO, GTLB, BZFD slide on earnings [3/14/2023 11:16 AM]
10-11-2022	AH	4:00 PM ET (Nov 10)	AMLX	Amylyx Pharmaceuticals, Inc.	2,010	-0.92	-0.97	0.00	Amylyx Pharmaceuticals GAAP EPS of -$0.92 beats by $0.04, revenue of $0.35M beats by $0.27M [11/10/2022 4:15 PM]	34.10	-1.29 (-3.63%)	34.25	-1.14 (-3.22%)	6.51 - 38.76	1,237,848	790,000	6,663
Amylyx Pharmaceuticals GAAP EPS of -$0.92 beats by $0.04, revenue of $0.35M beats by $0.27M [11/10/2022 4:15 PM] Checking on Amylyx Pharmaceuticals Ahead of Earnings [Nov-10-22 11:13AM] Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-10-22 04:01PM]
12-05-2022	AH		AMLX	Amylyx Pharmaceuticals, Inc.	446.00	-0.93	-0.75	0.00	Amylyx Pharmaceuticals GAAP EPS of -$0.93 misses by $0.19 [5/12/2022 5:11 PM]	8.56	1.08 (14.44%)	7.93	0.45 (6.02%)	6.51 - 33.41	105,267	270,000	207
Amylyx Pharmaceuticals GAAP EPS of -$0.93 misses by $0.19 [5/12/2022 5:11 PM] Amylyx Pharmaceuticals Reports First Quarter 2022 Financial Results [May-12-22 04:01PM]